The EVOS-HA is the first FDA cleared PEEK-OPTIMA Lumbar Interbody system in the US to be impregnated, not just coated, with Hydroxyapatite (HA). The innovative compound encourages bone growth while providing the strength, versatility, and advantages of its proven predecessor, PEEK-OPTIMA Natural.
Dr. Timothy Bassett of Northport Medical Center in Tuscaloosa, Alabama, performed the first EVOS-HA surgery in the United States on October 21, 2015, for an L4-L5 revision of a failed titanium cage and a non-union in addition to a L5-S1 TLIF.
"The EVOS-HA represents a significant step forward in the world of Lumbar Interbody fusions," said Dr. Bassett. "The combination of the new PEEK-OPTMA HA enhanced biomaterials with the anatomically contoured implant design, leads me to believe that the technology may help us obtain higher fusion rates, better subsidence resistance, lordosis, and overall cleaner line to line fit.” He added, “The improved modulus, in addition to the ability for bone on-growth to the implant, makes it an ideal material for biologic fusion."
“The EVOS-HA is our flagship product,” said Randy Roof, CES President and Co-Founder. “We officially launched the technology at the North American Spine Society 2015 Annual Meeting with tremendous success, and we are confident that the EVOS-HA will become the gold standard for patients suffering from degenerative lumbar disc disease in need of a fusion.”
The company is currently setting-up its distribution network throughout the United States.